Back to Search Start Over

Feasibility study of multimodal imaging for redox status and glucose metabolism in tumor.

Authors :
Kato, Kazuhiro
Yasui, Hironobu
Sato-Akaba, Hideo
Emoto, Miho C.
Fujii, Hirotada G.
Kmiec, Maciej M.
Kuppusamy, Periannan
Mizuno, Yuki
Kuge, Yuji
Nagane, Masaki
Yamashita, Tadashi
Inanami, Osamu
Source :
Free Radical Biology & Medicine. Jun2024, Vol. 218, p57-67. 11p.
Publication Year :
2024

Abstract

Understanding the tumor redox status is important for efficient cancer treatment. Here, we noninvasively detected changes in the redox environment of tumors before and after cancer treatment in the same individuals using a novel compact and portable electron paramagnetic resonance imaging (EPRI) device and compared the results with glycolytic information obtained through autoradiography using 2-deoxy-2-[18F]fluoro- d -glucose ([18F]FDG). Human colon cancer HCT116 xenografts were used in the mice. We used 3-carbamoyl-PROXYL (3CP) as a paramagnetic and redox status probe for the EPRI of tumors. The first EPRI was followed by the intraperitoneal administration of buthionine sulfoximine (BSO), an inhibitor of glutathione synthesis, or X-ray irradiation of the tumor. A second EPRI was performed on the following day. Autoradiography was performed after the second EPRI. After imaging, the tumor sections were evaluated by histological analysis and the amount of reducing substances in the tumor was measured. BSO treatment and X-ray irradiation significantly decreased the rate of 3CP reduction in tumors. Redox maps of tumors obtained from EPRI can be compared with tissue sections of approximately the same cross section. BSO treatment reduced glutathione levels in tumors, whereas X-ray irradiation did not alter the levels of any of the reducing substances. Comparison of the redox map with the autoradiography of [18F]FDG revealed that regions with high reducing power in the tumor were active in glucose metabolism; however, this correlation disappeared after X-ray irradiation. These results suggest that the novel compact and portable EPRI device is suitable for multimodal imaging, which can be used to study tumor redox status and therapeutic efficacy in cancer, and for combined analysis with other imaging modalities. [Display omitted] • Redox status change by cancer treatment were visualized in vivo by EPRI device. • Redox maps generated from EPR images were compared with tissue sections. • X-ray irradiation induced tissue oxidation in the redox environment of the tumor. • Comparison of redox maps and autoradiographic images of the tumor was enabled. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08915849
Volume :
218
Database :
Academic Search Index
Journal :
Free Radical Biology & Medicine
Publication Type :
Academic Journal
Accession number :
176868002
Full Text :
https://doi.org/10.1016/j.freeradbiomed.2024.03.028